Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / OTP-01
Other

OTP-01

Tracked across 1 events · 6 articles · First seen May 18, 2026 · Last active May 18, 2026

Sentiment
60
Attention
3
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
3 60
Business
LOTTE Biologics, Ottimo Pharma expand antibody agreement
Impact: OTP-01 is Ottimo Pharma's promising biparatopic antibody, which will be advanced toward launch readiness through the expanded collaboration with Lotte Biologics.
May 18, 2026 · 6 articles
ERGEN INTELLIGENCE
Track OTP-01 live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.